Simple and rapid liquid chromatography method for determination of efavirenz in plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 835, Issue 1-2, 2006, Pages 131-135

  Ramachandran, Geetha ^a   Kumar, A K Hemanth ^a   Swaminathan, Soumya ^a   Venkatesan, P ^a   Kumaraswami, V ^a   Greenblatt, David J ^b  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Efavirenz; HPLC; Plasma

Indexed keywords

ASSAYS; DRUG PRODUCTS; PHARMACOKINETICS; PLASMAS; ULTRAVIOLET DETECTORS;

EFAVIRENZ; ETHYL ACETATES; THERAPEUTIC DRUG MONITORING;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ACETAZOLAMIDE; ACETIC ACID ETHYL ESTER; AMITRIPTYLINE; COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; ETHAMBUTOL; FLUCONAZOLE; INDINAVIR; ISONIAZID; LAMIVUDINE; LOPERAMIDE; NELFINAVIR; NEVIRAPINE; OFLOXACIN; PHENYTOIN; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE; STREPTOMYCIN; ZIDOVUDINE;

ARTICLE; DRUG DETERMINATION; DRUG HALF LIFE; DRUG ISOLATION; DRUG MONITORING; DRUG STABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; LINEAR SYSTEM; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SAMPLE; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET RADIATION;

ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; OXAZINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33646475598     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.03.014     Document Type: Article

References (34)

1. Csajka C., Marzolini C., Fattinger K., Decosterd L.A., Fellay J., Telenti A., Biollaz J., and Buclin T. Clin. Pharmacol. Ther. 73 (2003) 20
2. J. Bartlett, R. Demasi, J. Quinn, C. Moxham, F. Rousseau, Proceedings of the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, 2000 (Abstract 519).
3. Gazzard B.G. HIV Med. 1 (2000) 11
4. D. Havlir, C. Hicks, J. Kahn, et al., Proceedings of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 1998 (Poster 1-104).
5. Haas D.W., Ribaudo H.J., Kim R.B., Tierney C., Wilkinson G.R., Gulick R.M., Clifford D.B., Hulgan T., Marzolini C., and Acosta E.P. AIDS 18 (2004) 2391
6. H.J. Ribaudo, D.B. Clifford, R.M. Gulick, C. Shikuma, K. Klingman, S. Snyder, E.P. Acosta, Program and abstracts of the 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, 2004 (Abstract 132).
7. Barrett J.S., Joshi A.S., Chai M., Ludden T.M., Fiske W.D., and Pieniaszek Jr. H.J. Int. J. Clin. Pharmacol. Ther. 40 (2002) 507
8. Fletcher C.V. Ann. Pharmacol. 33 (1999) 989
9. Lopez-Cortes L.F., Rauiz-Valderas R., Viciana P., Alarcon-Gonzalez A., Gomez-Mateos J., Leor-Jimenez E., Sarasa-Nacenta M., Lopez-Pua Y., and Pachon J. Clin. Pharmacokinet. 41 (2002) 681
10. Joly V., and Yeni P. AIDS Rev. 1 (1999) 37
11. Back D., Gatti G., Fletcher C., Garaffo R., Haubrich R., Hoetelmans R., Kurowski M., Luber A., Merry C., and Perno C.F. AIDS 16 Suppl. 1 (2002) S5
12. Langmann P., Weissbrich B., Desch S., Vath T., Schirmer D., Zilly M., and Klinker H. Eur. J. Med. Res. 7 (2002) 309
13. Stahle L., Moberg L., Svensson J.O., and Sonnerborg A. Ther. Drug Monit. 26 (2004) 267
14. Kappelhoff B.S., van Leth F., Robinson P.A., MacGregor T.R., Baraldi E., Montella F., Uip D.E., Thompson M.A., Lange J.M., Beijen J.H., and Huitema A.D. Antivir. Ther. 10 (2005) 489
15. Marzolini C., Telenti A., Decostered L.A., Greub G., Biollaz J., and Buclin T. AIDS 15 (2001) 71
16. Villani P., Pregnolato M., Banfo S., Rettani M., Burroni D., Seminari E., Maserati R., and Regazzi M.B. Ther. Drug Monit. 21 (1999) 346
17. Veldkamp A.I., van Heeswijk R.P., Meenhorst P.L., Mulder J.W., Lange J.M., Beijnen J.H., and Hoetelmans R.M. J. Chromatogr. B Biomed. Sci. Appl. 734 (1999) 55
18. Langmann P., Schirmer D., Vath T., Zilly M., and Klinker H. J. Chromatogr. B Biomed. Sci. Anal. 755 (2001) 151
19. Saras-Nacenta M., Lopez-Pua Y., Lopez-Cortes L.F., Mallolas J., Gatell J.M., and Carne X. J. Chromatogr. B Biomed. Sci. Appl. 763 (2001) 53
20. Matthews C.Z., Woolf E.J., Mazenko R.S., Haddix-Wiener H., Chavez-Eng C.M., Constanzer M.L., Doss G.A., and Matuszewski B.K. J. Pharm. Biomed. Anal. 28 (2002) 925
21. Aymard G., Legrand M., Trichereau N., and Diquet B. J. Chromatogr. B 744 (2000) 227
22. Titier K., Lagrange F., Pehourcq F., Edno-Mcheik L., Moore N., and Molimard M. Therapie 57 (2002) 169
23. Rezk N.L., Tidwell R.R., and Kashuba A.D.M. J. Chromatogr. B 774 (2002) 79
24. Boffito M., Tija J., Reynolds H.E., Hoggard P.G., Bonora S., Di Perri G., and Back D.J. Ther. Drug Monit. 24 (2002) 670
25. Cociglio M., Hillaire-Buys D., Peyriere H., and Alric R. Chromatogr. Sci. 41 (2003) 80
26. Usami Y., Oki T., Nakai M., Sagisaka M., and Kaneda T. Chem. Pharm. Bull. (Tokyo) 51 (2003) 715
27. Kappelhoff B.S., Rosing H., Huitema A.D., and Beijnen J.H. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 792 (2003) 353
28. Keil K., Frerichs V.A., DiFrancesco R., and Morse G. Ther. Drug Monit. 25 (2003) 340
29. Dailly E., Raffi F., and Jolliet P. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 813 (2004) 353
30. Poirier J.M., Robidou P., and Jaillon P. Ther. Drug Monit. 27 (2005) 186
31. Takahashi M., Yoshida M., Oki T., Okumura N., Suzuki T., and Kaneda T. Biol. Pharm. Bull. 28 (2005) 1286
32. Chenevier P., Massias L., Gueylard D., and Farinotti R. J. Chromatogr. B 708 (1998) 310
33. Investigational drug brochure: DMP 266, Wilmington, DE, The DuPont Merck Pharmaceutical Company, 1997.
34. Reddy Y.S., Gotzkowsky S.K., Eron J.J., Kim J.Y., Fiske W.D., Fiscus S.A., Petch L., Cohen M.S., and Kashuba A.D.M. J. Infect. Dis. 186 (2002) 1339